HEB Related Momentum Movers
-
BioCryst (BCRX) Continues Higher on Latest Bird Flu Death
-
Bird Flu Stocks Rise Again on Global Fears
-
Hemispherx Biopharma (HEB) Soars On Judgement Worth $1.40/Share, But Can They Collect
-
Traders Buying Hemispherx (HEB) Shares as Ampligen Manufacturing Concerns Addressed
-
Hemispherx (HEB) Jumps 10%+ as Chairman Discloses Small Purchase
-
Hemispherx (HEB) Falls 30% as FDA Recommends Another Ampligen Study, Says Can't Approve Application in Present Form
-
Hemispherx (HEB) Shares Breaking Out as $1 Technical Level Holds; Stock Up 23%
-
Hemispherx (HEB) Shares Tumble Amid Class Action Lawsuit by Shareholders
-
Hemispherx (HEB) Shares Down 15% Today and Down 45% Over Last Two Weeks
-
Hemispherx (HEB) To Widen Program for Chronic Fatigue Syndrome, Provides Update on Ampligen
-
Hemispherx (HEB) Off Highs As CEO Gives Nothing New
-
Hemispherx (HEB) Higher Ahead of Purported Update On Ampligen
-
Hemispherx (HEB) Shares Jumping as Data on Ampligen(R) Presented at Pacific Coast Oncology Gynecology Society Meeting
-
Swine Flu Stocks Could Be Hot As Fears Grow and Vaccine Production Put In Motion
-
Hemispherx (HEB) Announces Insufficient Votes Obtained for Passage of Proposal 3; Cancels Adjourned Stockholders' Meeting
-
Hemispherx Biopharma (HEB) Moving Higher Today
-
Swine Flu Stocks Catch a Bid on Sinovac News (SVA, AVII, HEB, DVAX, VICL)
-
Updates on Hemispherx Conference Call Fail to Sooth Investors (HEB)
-
Hemispherx (HEB) Surges on News Mgmt to Hold Conference Call Updating Influenza Research Initiatives
-
WHO Chief: Safe Swine Flu Vaccine Still 'Several Month's Away (NVAX, BCRX, HEB, more)
-
Traders Watching Russell High-Flyers For More Upside or New Shorts (ZN, BWEN, OPEN, CTIC, HEB)
-
Russell Index Additions See Upside Action On Reconstitution (BWEN, TZOO, MTXX, DDRX, MSSR)
-
Hemispherx Biopharma (HEB) Could Continue Wild Trading On Russell Index Addition
-
Hemispherx (HEB) Continues Wild Trading: Spikes 10% Mid-Day
-
Hemispherx (HEB) Shares Continue Lower as Traders Question Ampligen Approval
-
WHO to Hold Meeting of Pandemic Emergency Committee on Thursday as Swine Flu is Dangerously Close to 'Phase 6'
-
Volatility in Hemispherx (HEB) Remains: Stock Correcting Following Friday's 27% Sell-Off
-
Hemispherx Biopharma (HEB) Whacked Mid-Day On Wild Trading
-
Hemispherx Biopharma (HEB) Continues To Rip Higher On "Most Promising Mucosal Adjuvant for Influenza" Publication
-
Hemispherx (HEB) Continuing Higher as Japanese Researchers Call Ampligen(r) 'Most Promising' Candidate for Flu Vaccines
-
Shares of Hemispherx (HEB) Spike Mid-Day Ahead of Ampligen Approval/Rejection
-
Swine Flu Stock Rundown
-
U.S. Issues Public Health Emergency About Swine Flu
-
Bird Flu Stocks Up on Reports of Possible Human-to-Human Transmisson
-
Bird-Flu Stocks Continue Higher on News Indonesian Deaths May Be Human-to-Human Spread
-
Bird Flu Stocks Continue Higher After the Bell Tuesday
-
Bird Flu Stocks Higher as the Bird Flu Summit Starts
-
Bird Flu Stocks Higher On Spread of Deadly H5N1 Strain
-
Bird Flu Stock Higher After Human Cases in Turkey
-
China Reports 7th Human Bird Flu Case; Woman Died 12/21 - Dow Jones
-
China is confirming a new human bird flu case
-
Weak Strain of Bird Flu Found at a Sun Vally, California Quail Farm
-
China Acknowledges First Human Bird Flu Cases
-
BBC Reports Thai baby infected with lethal bird flu
-
China Reports New Bird Flu Outbreak In Central Province - Dow Jones
-
HEB Corrects Error Made in CNN Money Report
-
A Look at Yesterday’s Momentum Movers: ABGX, HEB, LMAI, HIET, ACTT, MSO, SNTO
-
HEB Said Ampligen Effective Adjuvant to Avian Influenza Treatments
-
Reports Birds Infected in Canada are Unlikely to Have the Deadly Strain
-
Unidentified H5 Bird Flu stain found in several Canadian birds
Back to HEB Stock Lookup
